Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma
Authors:
Open Access
- 9 December 2022
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 157, 337-351
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82073804)
- National Key Research and Development Program of China (2017YFA0205501)
This publication has 54 references indexed in Scilit:
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patientsNature, 2014
- A Novel Resorbable Embolization Microsphere for Transient Uterine Artery Occlusion: A Comparative Study with Trisacryl-Gelatin Microspheres in the Sheep ModelJournal of Vascular and Interventional Radiology, 2014
- Printed ionic-covalent entanglement hydrogels from carrageenan and an epoxy amineRSC Advances, 2014
- Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of theIDASPHEREphase I trialAlimentary Pharmacology & Therapeutics, 2014
- Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspectiveWorld Journal of Hepatology, 2014
- The Prognostic Value of 18F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)Theranostics, 2014
- Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinomaJournal of Hepatology, 2012
- Screening of anticancer drugs for chemoembolization of hepatocellular carcinomaAnti-Cancer Drugs, 2011
- Doxorubicin eluting beads—2: methods for evaluating drug elution and in-vitro:in-vivo correlationJournal of Materials Science: Materials in Medicine, 2007
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003